| Source: |
| DNA sequence encoding immunodominant fragment of Epstein-Barr Early Antigen expressed in Escherichia Coli. |
|
| Molecular weight: |
|
Recombinant EBV EA encodes the C terminal immunodominant sequence (306-390) of the Epstein-Barr Virus Early Antigen protein D BMRF1.
Recombinant EBV EA contains an N terminal GST purification tag and migrates as an approximately 36 kDa protein under non-reducing conditions conditions in SDS-PAGE.
|
|
| Purity: |
| >90%, as determined by SDS-PAGE. |
| |
| Applications: |
|
Recombinant human EBV EA antigen is suitable for ELISA and Western blots, excellent antigen for detection of EBV with minimal specificity problems.
|
| Specificity: |
Immunoreactive with sera of EBV infected individuals.
|
| Presentation: |
| 50mM Tris-HCl pH 8, 10mM glutathione, 60mM NaCl and 50% Glycerol. |
|
| |
|
| Storage: |
This protein can be stored in working aliquots at 2° - 8° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity.
Avoid repeated freeze/thaw cycles. |
|
| Usage: |
| This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
|
